Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Jakob W. Kist"'
Autor:
Janine B. Kastelijn, Leon M. G. Moons, Jakob W. Kist, Jip F. Prince, Maarten S. van Leeuwen, Miriam Koopman, Frank P. Vleggaar
Publikováno v:
Journal of gastrointestinal cancer. Humana Press
Kastelijn, J B, Moons, L M G, Kist, J W, Prince, J F, van Leeuwen, M S, Koopman, M & Vleggaar, F P 2022, ' Clinical Outcomes of Biliary Drainage in Patients with Malignant Biliary Obstruction Caused by Colorectal Cancer Metastases ', Journal of gastrointestinal cancer . https://doi.org/10.1007/s12029-022-00834-y
Kastelijn, J B, Moons, L M G, Kist, J W, Prince, J F, van Leeuwen, M S, Koopman, M & Vleggaar, F P 2022, ' Clinical Outcomes of Biliary Drainage in Patients with Malignant Biliary Obstruction Caused by Colorectal Cancer Metastases ', Journal of gastrointestinal cancer . https://doi.org/10.1007/s12029-022-00834-y
Background and aim Malignant biliary obstruction is an ominous complication of metastatic colorectal cancer (mCRC) that is challenging to solve. Biliary drainage can be performed to relieve symptoms of jaundice, treat cholangitis, or enable palliativ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c01cddbb021c3c19bab62239ada4f0cd
https://doi.org/10.1007/s12029-022-00834-y
https://doi.org/10.1007/s12029-022-00834-y
Autor:
Janine B, Kastelijn, Leon M G, Moons, Jakob W, Kist, Jip F, Prince, Maarten S, van Leeuwen, Miriam, Koopman, Frank P, Vleggaar
Publikováno v:
Journal of gastrointestinal cancer.
Malignant biliary obstruction is an ominous complication of metastatic colorectal cancer (mCRC) that is challenging to solve. Biliary drainage can be performed to relieve symptoms of jaundice, treat cholangitis, or enable palliative systemic therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::854a026f5db5f3ad8e71a8763230f47a
https://pubmed.ncbi.nlm.nih.gov/35608755
https://pubmed.ncbi.nlm.nih.gov/35608755
Autor:
F. J. Amelung, E. C. J. Consten, W. A. Draaisma, L. E. V. M. de Guerre, Jakob W. Kist, I. A. M. J. Broeders, P. M. Verheijen
Publikováno v:
BJS Open. 2:128-134
Background Stoma reversal is often considered a straightforward procedure with low short-term complication rates. The aim of this study was to determine the rate of incisional hernia following stoma reversal and identify risk factors for its developm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01faa14c3a185289ab0a6c00f6183e83
https://doi.org/10.1002/bjs5.48
https://doi.org/10.1002/bjs5.48
Autor:
I. H. M. Borel Rinkes, Schelto Kruijff, Patrick H. J. Hemmer, Menno R. Vriens, J. de Vries, Jakob W. Kist, Otis M. Vrielink, Kevin Wevers
Publikováno v:
Langenbeck's Archives of Surgery
Langenbeck's Archives of Surgery, 402(5), 767-773. Springer Verlag
Vrielink, O M, Wevers, K P, Kist, J W, Borel Rinkes, I H M, Hemmer, P H J, Vriens, M R, de Vries, J & Kruijff, S 2017, ' Laparoscopic anterior versus endoscopic posterior approach for adrenalectomy : a shift to a new golden standard? ', Langenbeck's Archives of Surgery, vol. 402, no. 5, pp. 767-773 . https://doi.org/10.1007/s00423-016-1533-x
Langenbecks Archives of Surgery, 402(5), 767-773. SPRINGER
Langenbeck's Archives of Surgery, 402(5), 767-773. Springer Verlag
Vrielink, O M, Wevers, K P, Kist, J W, Borel Rinkes, I H M, Hemmer, P H J, Vriens, M R, de Vries, J & Kruijff, S 2017, ' Laparoscopic anterior versus endoscopic posterior approach for adrenalectomy : a shift to a new golden standard? ', Langenbeck's Archives of Surgery, vol. 402, no. 5, pp. 767-773 . https://doi.org/10.1007/s00423-016-1533-x
Langenbecks Archives of Surgery, 402(5), 767-773. SPRINGER
PURPOSE: There has been an increased utilization of the posterior retroperitoneal approach (PRA) for adrenalectomy alongside the "classic" laparoscopic transabdominal technique (LTA). The aim of this study was to compare both procedures based on outc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68d3cc30d74915ae18591ea9d12dfd18
https://research.rug.nl/en/publications/b103dd59-e6d0-462f-ae4b-07cb5b7e72a3
https://research.rug.nl/en/publications/b103dd59-e6d0-462f-ae4b-07cb5b7e72a3
Autor:
Menno R. Vriens, Bart de Keizer, Jakob W. Kist, Ardine de Wit, Inne H.M. Borel Rinkes, Farahnaz Waissi, Thijs van Dalen, Gerlof D. Valk, Jos A. van der Hage, Lutske Lodewijk
Publikováno v:
Clinical Nuclear Medicine, 44(4), 272-275. Lippincott Williams and Wilkins
Clinical Nuclear Medicine, 44(4), 272. Lippincott Williams and Wilkins
Waissi, F, Kist, J W, Lodewijk, L, de Wit, A G, van der Hage, J A, van Dalen, T, de Keizer, B, Valk, G D, Borel Rinkes, I H M & Vriens, M R 2019, ' Fast-track Radioiodine Ablation Therapy After Thyroidectomy Reduces Sick Leave in Patients With Differentiated Thyroid Cancer (FASTHYNA Trial) ', Clinical Nuclear Medicine, vol. 44, no. 4, pp. 272-275 . https://doi.org/10.1097/RLU.0000000000002420
Clinical Nuclear Medicine, 44(4), 272. Lippincott Williams and Wilkins
Waissi, F, Kist, J W, Lodewijk, L, de Wit, A G, van der Hage, J A, van Dalen, T, de Keizer, B, Valk, G D, Borel Rinkes, I H M & Vriens, M R 2019, ' Fast-track Radioiodine Ablation Therapy After Thyroidectomy Reduces Sick Leave in Patients With Differentiated Thyroid Cancer (FASTHYNA Trial) ', Clinical Nuclear Medicine, vol. 44, no. 4, pp. 272-275 . https://doi.org/10.1097/RLU.0000000000002420
BACKGROUND: Recombinant human thyroid stimulating hormone (RhTSH) aided radioiodine ablative therapy (RIT) is current-day practice in the treatment of differentiated thyroid cancer (DTC). It is often planned 4 to 6 weeks after surgery or sometimes ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ed1d54a2b022a33c0269a1051cddd8e
https://research.vumc.nl/en/publications/f9953f7f-c1b1-46e4-8c1b-8077b514fa55
https://research.vumc.nl/en/publications/f9953f7f-c1b1-46e4-8c1b-8077b514fa55
Autor:
Miranda M. Snoeren, Bram Geurts, Lauran Stöger, Monique Brink, Dagmar Grob, Luuk J. Oostveen, Jip F. Prince, Cornelia M. Schaefer-Prokop, Ioannis Sechopoulos, Jakob W. Kist, Mathias Prokop, Rogier A van Dijk, Ewoud J. Smit
Publikováno v:
Radiology, 292, 1, pp. 197-205
Radiology, 292, 197-205
Radiology, 292, 197-205
Background Dual-energy CT iodine maps are used to detect pulmonary embolism (PE) with CT angiography but require dedicated hardware. Subtraction CT, a software-only solution, results in iodine maps with high contrast-to-noise ratios. Purpose To compa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddd1bacd5bdc6f58370d7ab0346a6b01
https://doi.org/10.1148/radiol.2019182666
https://doi.org/10.1148/radiol.2019182666
Autor:
Jakob W. Kist, Wessel M.C.M. Vorselaars, Helena M. Verkooijen, Inne H.M. Borel Rinkes, Gerlof D. Valk, Maarten W. Barentsz, Menno R. Vriens, Nick T.M. van der Meij, Lutske Lodewijk
Publikováno v:
Endocrine Practice. 22:561-566
The time between the moment of referral for the diagnostic workup for thyroid nodules and the outcome can be worrisome for patients. In general, patients experience high levels of anxiety during the evaluation of a lesion suspicious for cancer. There
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45ecb7d2fe89de1e0d9a9b58b9463c38
https://doi.org/10.4158/ep151036.or
https://doi.org/10.4158/ep151036.or
Autor:
Jakob W, Kist, Bart, de Keizer, Manfred, van der Vlies, Adrienne H, Brouwers, Dyde A, Huysmans, Friso M, van der Zant, Rick, Hermsen, Marcel P M, Stokkel, Otto S, Hoekstra, Wouter V, Vogel, Nils R L, Wagenaar
Publikováno v:
Journal of Nuclear Medicine, 57(5), 701-707. SOC NUCLEAR MEDICINE INC
Journal of Nuclear Medicine, 57(5), 701-707
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 57(5), 701-7
THYROPET Study Group 2016, ' 124I PET/CT to Predict the Outcome of Blind 131I Treatment in Patients with Biochemical Recurrence of Differentiated Thyroid Cancer : Results of a Multicenter Diagnostic Cohort Study (THYROPET) ', Journal of Nuclear Medicine, vol. 57, no. 5, pp. 701-707 . https://doi.org/10.2967/jnumed.115.168138
Journal of Nuclear Medicine, 57(5), 701-707. Society of Nuclear Medicine Inc.
Journal of Nuclear Medicine, 57(5), 701-707
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 57(5), 701-7
THYROPET Study Group 2016, ' 124I PET/CT to Predict the Outcome of Blind 131I Treatment in Patients with Biochemical Recurrence of Differentiated Thyroid Cancer : Results of a Multicenter Diagnostic Cohort Study (THYROPET) ', Journal of Nuclear Medicine, vol. 57, no. 5, pp. 701-707 . https://doi.org/10.2967/jnumed.115.168138
Journal of Nuclear Medicine, 57(5), 701-707. Society of Nuclear Medicine Inc.
UNLABELLED: Patients with suspected recurrence from differentiated thyroid carcinoma, based on an increased thyroglobulin (Tg) level and negative neck ultrasound (US), pose a clinical dilemma. Because standard imaging has a low yield identifying pote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad98e2fcc21ef25b5ac607ca2cbc8459
https://hdl.handle.net/11370/1b623b58-8b72-4b91-aef5-bd4e51934d5e
https://hdl.handle.net/11370/1b623b58-8b72-4b91-aef5-bd4e51934d5e
Autor:
Inne H.M. Borel Rinkes, Marcel P. M. Stokkel, Siegrid G. de Meer, Menno R. Vriens, Bart de Keizer, Gerlof D. Valk, Jakob W. Kist, Wessel M.C.M. Vorselaars
Publikováno v:
de Meer, S G A, Vorselaars, W M C M, Kist, J W, Stokkel, M P M, de Keizer, B, Valk, G D, Borel Rinkes, I H M & Vriens, M R 2017, ' Follow-up of patients with thyroglobulin-antibodies : Rising Tg-Ab trend is a risk factor for recurrence of differentiated thyroid cancer ', Endocrine Research, vol. 42, no. 4, pp. 302-310 . https://doi.org/10.1080/07435800.2017.1319858
Endocrine research, 42(4), 302. Informa Healthcare
Endocrine Research, 42(4), 302-310. Informa Healthcare
Endocrine research, 42(4), 302. Informa Healthcare
Endocrine Research, 42(4), 302-310. Informa Healthcare
PURPOSE: Differentiated thyroid cancer is the most common endocrine malignancy. Recurrences (5-20%) are the main reason for follow-up. Thyroglobulin (Tg) has proven to be an excellent disease marker, but thyroglobulin-antibodies (Tg-Ab) may interfere
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0add9527b0eb5cddb2c04bb3258aa797
https://research.vumc.nl/en/publications/f2079491-9788-44db-a3a3-ec9001a69456
https://research.vumc.nl/en/publications/f2079491-9788-44db-a3a3-ec9001a69456
Autor:
Jakob W. Kist, Onno Kranenburg, A.M. Prins, Menno R. Vriens, Lutske Lodewijk, Gerlof D. Valk, I. H. M. Borel Rinkes
Publikováno v:
Lodewijk, L, Prins, A M, Kist, J W, Valk, G D, Kranenburg, O, Rinkes, I H M B & Vriens, M R 2012, ' The value of miRNA in diagnosing thyroid cancer : a systematic review ', Cancer biomarkers : section A of Disease markers, vol. 11, no. 6, pp. 229-38 . https://doi.org/10.3233/CBM-2012-0273
Thyroid cancer is the most common endocrine neoplasm accounting for approximately 1,7% of total cancer diagnoses. The gold standard for evaluation of thyroid nodules is cytology from fine needle aspiration. In 30% of biopsies there is no conclusive d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a4415029b0538e139d08d4cab265f69
https://doi.org/10.3233/cbm-2012-0273
https://doi.org/10.3233/cbm-2012-0273